Results 121 to 130 of about 84,866 (261)

Glucagon‐like peptide‐1 receptor agonist use and violent crime among US adults

Criminology, EarlyView.
Abstract Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs), a class of medications widely prescribed for diabetes and obesity, have exhibited emerging effects on substance use, reward processing, and impulse control. This study examines whether current GLP‐1 RA use moderates established behavioral pathways to violent crime from impulsivity and ...
Daniel C. Semenza, Christopher Thomas
wiley   +1 more source

Trends in antipsychotic drug utilisation and indication in the paediatric population: a nationwide cohort study in Sweden. [PDF]

BMJ Ment Health
S Kamgang KH, Pasternak B, Reutfors J, Pradhan R, Wintzell V.   +4 more
europepmc   +1 more source

Clinical Intervention Following Detection of Incident Diabetes Within a Large Psychiatric Service System: A Chart Review Study

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Individuals with mental illness have a markedly reduced life expectancy, partly due to a significantly increased risk of developing type 2 diabetes, driven by lifestyle factors and the adverse metabolic effects of psychotropic medications.
Pernille Kølbæk, Christopher Rohde, Maria Speed, Henrik Holm Thomsen, Søren Dinesen Østergaard   +4 more
wiley   +1 more source

A systematic review using the Theoretical Domains Framework to identify barriers and facilitators to the adoption of prescribing guidelines

International Journal of Pharmacy Practice, EarlyView., 2020
Abstract Objectives Evidence‐based guidelines have the potential to reduce variation and increase prescribing quality. Identifying the key determinants to their uptake, using a theory‐based approach, may assist in the design of successful interventions to increase their adoption into practice.
Paulina Paksaite, Margaret Watson, Joel Crosskey, Eni Sula, Celine West   +4 more
wiley   +1 more source

Trends in recorded deaths involving antipsychotics: The role of deprivation, ethnicity, and regional disparities. [PDF]

PLoS One
Khan MU, Hasan SS.
europepmc   +1 more source

Electroconvulsive Therapy and Time to Psychiatric Readmission in Schizophrenia

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction There is evidence that electroconvulsive therapy (ECT) can augment the effects of antipsychotics in schizophrenia. However, there is limited evidence from Western populations on whether ECT reduces the risk of relapse compared to non‐ECT treatment in schizophrenia.
Linnea Stenmark, Mussie Msghina, Axel Nordenskjöld   +2 more
wiley   +1 more source

Three-week effect of amisulpride, aripiprazole, and olanzapine on gene expression in peripheral blood in individuals with schizophrenia spectrum disorders. [PDF]

Int J Neuropsychopharmacol
Torsvik A, Trentani A, Stokowy TK, Skrede S, Joa I, Klæbo Reitan SM, Rettenbacher M, Kroken RA, Johnsen E, Steen VM.   +9 more
europepmc   +1 more source

Atypical antipsychotics, more than just an antipsychotic

Neural Regeneration Research, 2020
Hiram Tendilla-Beltrán, Gonzalo Flores
openaire   +3 more sources

Use of Glucagon‐Like Peptide 1 Receptor Agonists and the Associated Risk of Hospitalisation in Bipolar Disorder, From a Nationwide Cohort, 2009–2024

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Diabetes, obesity and bipolar disorder often co‐occur and may have shared pathophysiology. Glucagon‐like peptide 1 receptor agonists (GLP‐1RA) treat diabetes and obesity but their impact on bipolar disorder is unknown. In this era of stagnated pharmacotherapy, we examined psychiatric hospitalisation and absence from work due to ...
Heidi Taipale, Mark Taylor, Markku Lähteenvuo, Ellenor Mittendorfer‐Rutz, Antti Tanskanen, Jari Tiihonen   +5 more
wiley   +1 more source

Real-world antipsychotic prescribing pathways and treatment modifications in schizophrenia spectrum disorders: evidence from the United Arab Emirates. [PDF]

Front Pharmacol
Bokhari SA, Elnoor M, Javaid SF, Alnor MA.   +3 more
europepmc   +1 more source